Verrica Pharmaceuticals Inc.

NASDAQ:VRCA

0.5373 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Revenue 7.5665.1249.0321200000
Cost of Revenue 1.8530.7460.7250.4720.2290.2570.0200
Gross Profit 5.7134.3788.30711.528-0.229-0.257-0.0200
Gross Profit Ratio 0.7550.8540.920.96100000
Reseach & Development Expenses 11.8420.29512.19815.92915.67315.43612.8263.731.709
General & Administrative Expenses 0017.40526.97924.50814.6449.0520.7270.204
Selling & Marketing Expenses 000000000
SG&A 58.82247.30517.40526.97924.50814.6449.0520.7270.204
Other Expenses 0.972.537-0.0580-0.0011.873-0.00100
Operating Expenses 71.63270.13729.60342.90840.18130.0821.8784.4571.913
Operating Income -65.919-65.759-21.296-30.908-40.181-30.08-21.878-4.457-1.913
Operating Income Ratio -8.713-12.834-2.358-2.57600000
Total Other Income Expenses Net -10.66-1.236-3.191-4.172-2.5131.8731.23-0.0020
Income Before Tax -76.579-66.995-24.487-35.08-42.694-28.207-20.648-4.459-1.913
Income Before Tax Ratio -10.121-13.075-2.711-2.92300000
Income Tax Expense 003.1913.8232.803-0.2571.23-4.457-1.913
Net Income -76.579-66.995-27.678-38.903-45.497-27.95-20.648-4.459-1.913
Net Income Ratio -10.121-13.075-3.064-3.24200000
EPS -1.48-1.48-0.81-1.44-1.82-1.12-1.41-0.22-0.096
EPS Diluted -1.48-1.48-0.81-1.44-1.82-1.12-1.41-0.22-0.096
EBITDA -65.898-62.197-21.597-30.313-39.432-30.08-20.628-4.457-1.913
EBITDA Ratio -8.71-12.138-2.312-2.56500000